...
首页> 外文期刊>Journal of Clinical Microbiology >Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae.
【24h】

Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae.

机译:酶免疫法检测肺炎支原体的免疫球蛋白M(IgM)和IgG抗体。

获取原文
           

摘要

An enzyme immunoassay (EIA) for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae was developed. The EIA was evaluated on the basis of results in the M. pneumoniae complement fixation (MPCF) test and the cold agglutinin test. Serum samples from 430 patients with respiratory infections of known or unknown etiology, from 91 healthy children and adults and from 20 patients with rheumatoid factor, were investigated. By the criteria chosen for positive diagnostic EIA values, we found that the combined measurement of specific IgM and IgG gave a specificity of 99.7% and a sensitivity of 97.8%. If only IgM antibodies were measured, the specificity was 100% and the sensitivity was 88%. For IgG alone the specificity was 99.7%, but the sensitivity was only 46% because of the high EIA cutoff value chosen for IgG. We found no false positives among serum samples from patients with non-M. pneumoniae respiratory infection of known etiology, and there were no false IgM positives due to rheumatoid factor. In some cases the IgM EIA results became positive earlier in the course of illness than the MPCF titer. While children and teenagers responded predominantly with IgM antibodies, patients older than 40 years often had an IgG response only (56% of cases), probably because of reinfection. We conclude that this EIA is a good alternative to the combined MPCF and cold agglutinin tests in the diagnosis of M. pneumoniae infection.
机译:开发了用于检测针对肺炎支原体的免疫球蛋白M(IgM)和IgG抗体的酶免疫法(EIA)。根据肺炎支原体补体固定试验(MPCF)和冷凝集素试验的结果评估EIA。调查了430名病因已知或未知的呼吸道感染患者,91名健康儿童和成人以及20名类风湿因子患者的血清样本。通过选择用于阳性EIA诊断值的标准,我们发现特定IgM和IgG的组合测量得出的特异性为99.7%,灵敏度为97.8%。如果仅测量IgM抗体,则特异性为100%,灵敏度为88%。对于单独的IgG,特异性为99.7%,但是由于针对IgG选择了高的EIA截止值,因此灵敏度仅为46%。我们发现非M患者的血清样本中没有假阳性。肺炎性呼吸道感染的病因已知,没有因类风湿因子引起的假IgM阳性。在某些情况下,IgM EIA结果在疾病过程中比MPCF滴度更早呈阳性。儿童和青少年主要以IgM抗体应答,而40岁以上的患者通常仅发生IgG应答(占病例的56%),这可能是由于再次感染所致。我们得出的结论是,此EIA是组合MPCF和冷凝集素试验在肺炎支原体感染诊断中的良好替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号